{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Neuroleptic Malignant Syndrome: A Case Report

Activity Steps

Purpose of Activity

To provide information on the identification and treatment of NMS.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the clinical manifestations of NMS.
  2. List the risk factors for NMS.
  3. Summarize treatment options for patients with NMS.
Price: $17.95


  • ANCC 1.5 CH / 0.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: N0420A
Published: Apr 2020
Expires: 3/4/2022
Sources: Nursing2021
Required Passing Score: 14/19 (73%)
Authors: Lisa A. Ruth-Sahd DEd, RN, CCRN, CEN, CNE; Darris Rodrigues BSN, RN; Elizabeth Shreve